Endothelial cell infection and endotheliitis in COVID-19.

作者: Zsuzsanna Varga , Andreas J Flammer , Peter Steiger , Martina Haberecker , Rea Andermatt

DOI: 10.1016/S0140-6736(20)30937-5

关键词:

摘要: Cardiovascular complications are rapidly emerging as a key threat in coronavirus disease 2019 (COVID-19) in addition to respiratory disease. The mechanisms underlying the …

参考文章(16)
Stefano Taddei, Agostino Virdis, Lorenzo Ghiadoni, Paola Mattei, Antonio Salvetti, Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. Journal of Hypertension. ,vol. 16, pp. 447- 456 ,(1998) , 10.1097/00004872-199816040-00006
Carlos M. Ferrario, Jewell Jessup, Mark C. Chappell, David B. Averill, K. Bridget Brosnihan, E. Ann Tallant, Debra I. Diz, Patricia E. Gallagher, Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2 Circulation. ,vol. 111, pp. 2605- 2610 ,(2005) , 10.1161/CIRCULATIONAHA.104.510461
Andreas J. Flammer, Todd Anderson, David S. Celermajer, Mark A. Creager, John Deanfield, Peter Ganz, Naomi M. Hamburg, Thomas F. Lüscher, Michael Shechter, Stefano Taddei, Joseph A. Vita, Amir Lerman, The Assessment of Endothelial Function Circulation. ,vol. 126, pp. 753- 767 ,(2012) , 10.1161/CIRCULATIONAHA.112.093245
David Hürlimann, Adrian Forster, Georg Noll, Frank Enseleit, Rémy Chenevard, Oliver Distler, Markus Béchir, Lukas E. Spieker, Michel Neidhart, Beat A. Michel, Renate E. Gay, Thomas F. Lüscher, Steffen Gay, Frank Ruschitzka, Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis Circulation. ,vol. 106, pp. 2184- 2187 ,(2002) , 10.1161/01.CIR.0000037521.71373.44
Andreas J. Flammer, Isabella Sudano, Frank Hermann, Steffen Gay, Adrian Forster, Michel Neidhart, Peter Künzler, Frank Enseleit, Daniel Périat, Matthias Hermann, Juerg Nussberger, Thomas F. Luscher, Roberto Corti, Georg Noll, Frank Ruschitzka, Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis Circulation. ,vol. 117, pp. 2262- 2269 ,(2008) , 10.1161/CIRCULATIONAHA.107.734384
Piero O. Bonetti, Lilach O. Lerman, Amir Lerman, Endothelial Dysfunction A Marker of Atherosclerotic Risk Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 23, pp. 168- 175 ,(2003) , 10.1161/01.ATV.0000051384.43104.FC
Todd J. Anderson, Ian T. Meredith, Alan C. Yeung, Balz Frei, Andrew P. Selwyn, Peter Ganz, The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion The New England Journal of Medicine. ,vol. 332, pp. 488- 493 ,(1995) , 10.1056/NEJM199502233320802
Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, Bin Cao, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. ,vol. 395, pp. 1054- 1062 ,(2020) , 10.1016/S0140-6736(20)30566-3
Richard Horton, Offline: COVID-19—bewilderment and candour The Lancet. ,vol. 395, pp. 1178- ,(2020) , 10.1016/S0140-6736(20)30850-3
Marc Feldmann, Ravinder N Maini, James N Woody, Stephen T Holgate, Gregory Winter, Matthew Rowland, Duncan Richards, Tracy Hussell, Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. The Lancet. ,vol. 395, pp. 1407- 1409 ,(2020) , 10.1016/S0140-6736(20)30858-8